CONMED (CNMD) PT Raised to $129 at Needham & Company
Get Alerts CNMD Hot Sheet
Price: $46.30 +0.17%
Rating Summary:
5 Buy, 11 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 3 | Down: 5 | New: 34
Rating Summary:
5 Buy, 11 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 3 | Down: 5 | New: 34
Join SI Premium – FREE
Needham & Company analyst Mike Matson raised the price target on CONMED (NYSE: CNMD) to $129.00 (from $119.00) while maintaining a Buy rating.
You May Also Be Interested In
- JPMorgan Downgrades Bukit Asam Tbk PT (PTBA:IJ) to Underweight
- Visual Photonics Epitaxy Co Ltd (2455:TT) PT Raised to NT$846 at Macquarie
- HubSpot Inc (HUBS) PT Raised to $225 at Stifel Ahead of UNBOUND Conference
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share